Physician

Gregory Ryan Sutton, M.D.

According to 2025 Medicare claims, Gregory Sutton, M.D. (NPI: 1255575270) practices hematology/oncology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Walker, GA. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY PLLC (NPI: 1811955917; TIN: 621647259) and primary practice location at 30736-5168.

Sutton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 897 traditional Medicare patients, billed 181,898 HCPCS/CPT codes, and received $3,999,814 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,986 prescription claims across 506 beneficiaries totaling $8,640,639 in drug costs, led by Revlimid (Lenalidomide). DME data shows 40 claims. Open Payments data shows 68 records totaling $1,545. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $299,936 to $3,999,814. Similarly, Part D prescription costs have moved sharply higher in recent years, from $98,102 to $8,640,639. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,497 to $9,154.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	260	36,931	$299,936
2016	605	133,098	$1,101,442
2017	632	146,653	$1,301,316
2018	560	152,594	$1,524,514
2019	647	212,364	$1,720,403
2020	617	196,155	$1,880,834
2021	731	189,618	$2,611,961
2022	755	237,981	$2,910,707
2023	971	266,575	$3,940,862
2024	897	181,898	$3,999,814

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	108	285	$98,102
2016	235	1,227	$1,297,758
2017	251	1,535	$2,043,110
2018	293	1,676	$2,097,680
2019	339	2,340	$3,067,287
2020	336	2,150	$2,867,247
2021	371	2,233	$3,968,068
2022	424	2,704	$4,559,930
2023	518	2,814	$5,210,371
2024	506	2,986	$8,640,639

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$13,193
2016	N/R	N/R	N/R
2017	N/R	13	$7,665
2018	N/R	87	$38,125
2019	N/R	35	$1,115
2020	N/R	26	$1,026
2021	N/R	N/R	N/R
2022	N/R	37	$1,309
2023	N/R	80	$14,713
2024	N/R	40	$2,129

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	348	489	$83
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	313	597	$12
80053	Blood test, comprehensive group of blood chemicals	597	2,002	$10
36415	Insertion of needle into vein for collection of blood sample	654	2,226	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	753	2,899	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	79	2,138	$1,308,902
Nubeqa	Darolutamide	94	2,820	$1,097,472
Imbruvica	Ibrutinib	43	1,204	$707,353
Ibrance	Palbociclib	45	1,260	$673,702
Xtandi	Enzalutamide	41	1,230	$533,227

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$1,546
J8700	Temozolomide, oral, 5 mg	N	N/R	13	$382
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$201

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	68	$1,545	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gregory Ryan Sutton, M.D.?

Tedicare shows public-source Medicare data for Gregory Ryan Sutton, M.D. (NPI 1255575270), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory Ryan Sutton, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gregory Ryan Sutton, M.D.?

Gregory Ryan Sutton, M.D. is linked to TENNESSEE ONCOLOGY PLLC (billing NPI 1811955917) in the available physician profile data.

Does Gregory Ryan Sutton, M.D. have Open Payments data?

Gregory Ryan Sutton, M.D. has 68 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.